Intellectual Property India Publishes Patent Application for 'Deuterated Analogs Of Etifoxine And Methods Of Administration Without Autoinduction Of Metabolism' Filed by Gaba Therapeutics Inc.

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202527050094 A) filed by Gaba Therapeutics Inc., Newport Beach, U.S.A., on May 24, for 'deuterated analogs of etifoxine and methods of administration without autoinduction of metabolism.'

Inventor(s) include Dasse, Olivier; and Saltarelli, Mario.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to deuterated etifoxine compositions and methods for administration without autoinduction of metabolism in the treatment of a variety of diseases, disorders, or conditions."

The patent application was internationally filed on Oct. 24, 2023, under International application No.PCT/US2023/077643.

Disclaimer: Curated by HT Syndication.